US equities
|
META
$638.48
▼-0.64%
SPCX
$145.71
▼-1.21%
MU
$890.00
▲+1.42%
TSLA
$386.91
▲+3.95%
NVDA
$213.41
▲+1.16%
NU
$11.92
▼-21.37%
SNDK
$1,249.50
▲+0.93%
MELI
$1,629.64
▼-9.97%
META
$638.48
▼-0.64%
SPCX
$145.71
▼-1.21%
MU
$890.00
▲+1.42%
TSLA
$386.91
▲+3.95%
NVDA
$213.41
▲+1.16%
NU
$11.92
▼-21.37%
SNDK
$1,249.50
▲+0.93%
MELI
$1,629.64
▼-9.97%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Inovio Pharmaceuticals, Inc. - Common Stock
(NQ:
INO
)
0.9213
+0.0242 (+2.70%)
Delayed Quote
Updated: 9:30 AM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inovio Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
INO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
March 27, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
March 25, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
March 24, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
March 24, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
March 23, 2026
From
Schall Law
Via
GlobeNewswire
Robbins LLP Reminds Inovio Pharmaceuticals, Inc. Stockholders of the Pending Class Action Against INO and Urges Harmed Stockholders to Seek More Information
March 20, 2026
From
Robbins LLP
Via
Business Wire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
March 19, 2026
From
Schall Law
Via
GlobeNewswire
INO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
March 18, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Inovio (INO) Q4 2025 Earnings Call Transcript
↗
March 17, 2026
Inovio (INO) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
March 16, 2026
From
Schall Law
Via
GlobeNewswire
Inovio Stock Up On Earnings, Pipeline Progress
↗
March 13, 2026
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher on Friday morning after the company reported fourth-quarter results.
Via
Benzinga
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
March 13, 2026
From
Schall Law
Via
GlobeNewswire
INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
March 13, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
March 10, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
March 10, 2026
From
Schall Law
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PomDoctor and Inovio and Encourages Investors to Contact the Firm
March 09, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO
March 06, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
March 06, 2026
From
Schall Law
Via
GlobeNewswire
UPCOMING DEADLINE: Inovio Pharmaceuticals (INO) Securities Fraud Class Action – April 7, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP
March 04, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
March 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
March 03, 2026
From
Schall Law
Via
GlobeNewswire
INO CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
February 25, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO
February 25, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
February 24, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
February 24, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
February 24, 2026
From
Schall Law
Via
GlobeNewswire
Is Inovio Pharmaceuticals Stock Going to $0?
↗
February 23, 2026
This forgotten stock might be too risky even for contrarian investors.
Via
The Motley Fool
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
February 20, 2026
From
Schall Law
Via
GlobeNewswire
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
February 20, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
